Edwards Lifesciences Corporation (EW) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 49.85B |
| Enterprise Value | 47.62B |
| P/E Ratio | 58.76 |
| PEG Ratio | -2.44 |
| Price/Sales Ratio | 8.96 |
| Price/Book Ratio | 5.52 |
| Enterprise/Revenue | 8.6 |
| Enterprise/EBITDA | 35.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.15 |
| Operating Margin | 0.26 |
| Return On Assets | 0.07 |
| Return On Equity | 0.1 |
| Revenue | 6.07B |
| Revenue/Share | 11.58 |
| Gross Profit | 4.74B |
| EBITDA | 1.43B |
| Net Income | 1.07B |
| Diluted EPS | 1.83 |
| Total Cash | 4.64B |
| Total Cash/Share | 8.06 |
| Total Debt | 704.5M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 4.6 |
| Book Value Per Share | 19.02 |
| 52-Week Change | 22.13 |
| 52-Week High | 105.37 |
| 52-Week Low | 74.66 |
| Moving Average 50 Days | 89.48 |
| Moving Average 200 Days | 85.98 |
| Average Volume | 3.75M |
| Shares Outstanding | 575M |
| % Held by Institutions | 90.75 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
| Last Split Date | June 01, 2020 |